A citation-based method for searching scientific literature

Andrew Dunbar, Abbas Nazir, Ross Levine. Curr Protoc Pharmacol 2017
Times Cited: 14







List of co-cited articles
148 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli,[...]. Nature 2005
50

JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease.
Juan Li, David G Kent, Anna L Godfrey, Harriet Manning, Jyoti Nangalia, Athar Aziz, Edwin Chen, Kourosh Saeb-Parsy, Juergen Fink, Rachel Sneade,[...]. Blood 2014
65
50

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.
Ralph Tiedt, Hui Hao-Shen, Marta A Sobas, Renate Looser, Stephan Dirnhofer, Jürg Schwaller, Radek C Skoda. Blood 2008
344
50

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Ross L Levine, Martha Wadleigh, Jan Cools, Benjamin L Ebert, Gerlinde Wernig, Brian J P Huntly, Titus J Boggon, Iwona Wlodarska, Jennifer J Clark, Sandra Moore,[...]. Cancer Cell 2005
42


JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.
Juan Li, Dominik Spensberger, Jong Sook Ahn, Shubha Anand, Philip A Beer, Cedric Ghevaert, Edwin Chen, Ariel Forrai, Linda M Scott, Rita Ferreira,[...]. Blood 2010
164
42

Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model.
Gerlinde Wernig, Thomas Mercher, Rachel Okabe, Ross L Levine, Benjamin H Lee, D Gary Gilliland. Blood 2006
383
35

Somatic mutations of calreticulin in myeloproliferative neoplasms.
Thorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, Harini Nivarthi, Elisa Rumi, Jelena D Milosevic, Nicole C C Them, Tiina Berg, Bettina Gisslinger, Daniela Pietra,[...]. N Engl J Med 2013
35

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.
E Joanna Baxter, Linda M Scott, Peter J Campbell, Clare East, Nasios Fourouclas, Soheila Swanton, George S Vassiliou, Anthony J Bench, Elaine M Boyd, Natasha Curtin,[...]. Lancet 2005
35

Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells.
Ann Mullally, Steven W Lane, Brian Ball, Christine Megerdichian, Rachel Okabe, Fatima Al-Shahrour, Mahnaz Paktinat, J Erika Haydu, Elizabeth Housman, Allegra M Lord,[...]. Cancer Cell 2010
274
35

JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα.
Salma Hasan, Catherine Lacout, Caroline Marty, Marie Cuingnet, Eric Solary, William Vainchenker, Jean-Luc Villeval. Blood 2013
104
35


The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm.
Veena Sangkhae, S Leah Etheridge, Kenneth Kaushansky, Ian S Hitchcock. Blood 2014
57
28

Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
Caroline Marty, Christian Pecquet, Harini Nivarthi, Mira El-Khoury, Ilyas Chachoua, Micheline Tulliez, Jean-Luc Villeval, Hana Raslova, Robert Kralovics, Stefan N Constantinescu,[...]. Blood 2016
182
28

Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.
Shannon Elf, Nouran S Abdelfattah, Edwin Chen, Javier Perales-Patón, Emily A Rosen, Amy Ko, Fabian Peisker, Natalie Florescu, Silvia Giannini, Ofir Wolach,[...]. Cancer Discov 2016
179
28

A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Robert Kralovics, Francesco Passamonti, Andreas S Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R Passweg, Andre Tichelli, Mario Cazzola, Radek C Skoda. N Engl J Med 2005
28

Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
Jacob Grinfeld, Jyoti Nangalia, E Joanna Baxter, David C Wedge, Nicos Angelopoulos, Robert Cantrill, Anna L Godfrey, Elli Papaemmanuil, Gunes Gundem, Cathy MacLean,[...]. N Engl J Med 2018
303
28


Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.
Raajit Rampal, Fatima Al-Shahrour, Omar Abdel-Wahab, Jay P Patel, Jean-Philippe Brunel, Craig H Mermel, Adam J Bass, Jennifer Pretz, Jihae Ahn, Todd Hricik,[...]. Blood 2014
270
28

JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.
Catherine Lacout, Didier F Pisani, Micheline Tulliez, Françoise Moreau Gachelin, William Vainchenker, Jean-Luc Villeval. Blood 2006
335
28

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Pontus Lundberg, Axel Karow, Ronny Nienhold, Renate Looser, Hui Hao-Shen, Ina Nissen, Sabine Girsberger, Thomas Lehmann, Jakob Passweg, Martin Stern,[...]. Blood 2014
418
28

Effect of mutation order on myeloproliferative neoplasms.
Christina A Ortmann, David G Kent, Jyoti Nangalia, Yvonne Silber, David C Wedge, Jacob Grinfeld, E Joanna Baxter, Charles E Massie, Elli Papaemmanuil, Suraj Menon,[...]. N Engl J Med 2015
339
28

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Giulio Genovese, Anna K Kähler, Robert E Handsaker, Johan Lindberg, Samuel A Rose, Samuel F Bakhoum, Kimberly Chambert, Eran Mick, Benjamin M Neale, Menachem Fromer,[...]. N Engl J Med 2014
28

Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice.
Shu Xing, Tina Ho Wanting, Wanming Zhao, Junfeng Ma, Shaofeng Wang, Xuesong Xu, Qingshan Li, Xueqi Fu, Mingjiang Xu, Zhizhuang Joe Zhao. Blood 2008
162
28

Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms.
Maria Kleppe, Richard Koche, Lihua Zou, Peter van Galen, Corinne E Hill, Lauren Dong, Sofie De Groote, Efthymia Papalexi, Amritha V Hanasoge Somasundara, Keith Cordner,[...]. Cancer Cell 2018
119
28

Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera.
Ann Mullally, Claudia Bruedigam, Luke Poveromo, Florian H Heidel, Amy Purdon, Therese Vu, Rebecca Austin, Dirk Heckl, Lawrence J Breyfogle, Catherine Paine Kuhn,[...]. Blood 2013
113
28

Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms.
Marito Araki, Yinjie Yang, Nami Masubuchi, Yumi Hironaka, Hiraku Takei, Soji Morishita, Yoshihisa Mizukami, Shin Kan, Shuichi Shirane, Yoko Edahiro,[...]. Blood 2016
178
21

Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice.
Caroline Marty, Catherine Lacout, Antoine Martin, Salma Hasan, Sylvie Jacquot, Marie-Christine Birling, William Vainchenker, Jean-Luc Villeval. Blood 2010
126
21

Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.
Ilyas Chachoua, Christian Pecquet, Mira El-Khoury, Harini Nivarthi, Roxana-Irina Albu, Caroline Marty, Vitalina Gryshkova, Jean-Philippe Defour, Gaëlle Vertenoeil, Anna Ngo,[...]. Blood 2016
219
21

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
J Nangalia, C E Massie, E J Baxter, F L Nice, G Gundem, D C Wedge, E Avezov, J Li, K Kollmann, D G Kent,[...]. N Engl J Med 2013
21

JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.
William Vainchenker, Emilie Leroy, Laure Gilles, Caroline Marty, Isabelle Plo, Stefan N Constantinescu. F1000Res 2018
90
21

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator.
Takuro Kameda, Kotaro Shide, Takumi Yamaji, Ayako Kamiunten, Masaaki Sekine, Yasuhiro Taniguchi, Tomonori Hidaka, Yoko Kubuki, Haruko Shimoda, Kousuke Marutsuka,[...]. Blood 2015
58
21

Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F.
K Shide, H K Shimoda, T Kumano, K Karube, T Kameda, K Takenaka, S Oku, H Abe, K S Katayose, Y Kubuki,[...]. Leukemia 2008
139
21

Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling.
Edwin Chen, Philip A Beer, Anna L Godfrey, Christina A Ortmann, Juan Li, Ana P Costa-Pereira, Catherine E Ingle, Emmanouil T Dermitzakis, Peter J Campbell, Anthony R Green. Cancer Cell 2010
131
21

Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms.
Edwin Chen, Rebekka K Schneider, Lawrence J Breyfogle, Emily A Rosen, Luke Poveromo, Shannon Elf, Amy Ko, Kristina Brumme, Ross Levine, Benjamin L Ebert,[...]. Blood 2015
74
21

Characterization of murine JAK2V617F-positive myeloproliferative disease.
Thomas G P Bumm, Collin Elsea, Amie S Corbin, Marc Loriaux, Daniel Sherbenou, Lisa Wood, Jutta Deininger, Richard T Silver, Brian J Druker, Michael W N Deininger. Cancer Res 2006
158
21

Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing.
Alba Rodriguez-Meira, Gemma Buck, Sally-Ann Clark, Benjamin J Povinelli, Veronica Alcolea, Eleni Louka, Simon McGowan, Angela Hamblin, Nikolaos Sousos, Nikolaos Barkas,[...]. Mol Cell 2019
114
21

Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo.
Brittany Woods, Wei Chen, Sophia Chiu, Christian Marinaccio, Chunling Fu, Lilly Gu, Marinka Bulic, Qiong Yang, Anouar Zouak, Shengxian Jia,[...]. Clin Cancer Res 2019
33
21

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
21

Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice.
Christoph Walz, Wesam Ahmed, Katherine Lazarides, Monica Betancur, Nihal Patel, Lothar Hennighausen, Virginia M Zaleskas, Richard A Van Etten. Blood 2012
128
21

Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Mingchao Xie, Charles Lu, Jiayin Wang, Michael D McLellan, Kimberly J Johnson, Michael C Wendl, Joshua F McMichael, Heather K Schmidt, Venkata Yellapantula, Christopher A Miller,[...]. Nat Med 2014
21

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.
S Koschmieder, T I Mughal, H C Hasselbalch, G Barosi, P Valent, J-J Kiladjian, G Jeryczynski, H Gisslinger, J S Jutzi, H L Pahl,[...]. Leukemia 2016
103
21


Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations.
Rebecca J Austin, Jasmin Straube, Claudia Bruedigam, Gabor Pali, Sebastien Jacquelin, Therese Vu, Joanne Green, Julius Gräsel, Lianne Lansink, Leanne Cooper,[...]. Leukemia 2020
21
21

Haematopoiesis in the era of advanced single-cell technologies.
Sten Eirik W Jacobsen, Claus Nerlov. Nat Cell Biol 2019
54
21

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
21

Myeloproliferative neoplasms: from origins to outcomes.
Jyoti Nangalia, Anthony R Green. Hematology Am Soc Hematol Educ Program 2017
17
21

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.
D Pietra, E Rumi, V V Ferretti, C A Di Buduo, C Milanesi, C Cavalloni, E Sant'Antonio, V Abbonante, F Moccia, I C Casetti,[...]. Leukemia 2016
170
14


MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Yana Pikman, Benjamin H Lee, Thomas Mercher, Elizabeth McDowell, Benjamin L Ebert, Maricel Gozo, Adam Cuker, Gerlinde Wernig, Sandra Moore, Ilene Galinsky,[...]. PLoS Med 2006
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.